Physician profile
Danielle M Moore
NPI 1174113864
$922.92
in general payments reported to CMS, 2019-2025
12 companies · $35.54 in 2025
The $35.54 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.77 · 2023: $597 · 2024: $259 · 2025: $35.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.16 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $360.85 | 2023 | |
| Astellas Pharma US INC | $212.08 | 2024 | Veozah |
| Inari Medical, INC. | $98.41 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Exact Sciences Corporation | $51.10 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $49.57 | 2023-2024 | |
| Mylan Specialty L.P. | $30.63 | 2023-2024 | Yupelri |
| Idorsia Pharmaceuticals US INC | $28.36 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $21.70 | 2023 | Breztri |
| Sanofi Pasteur INC. | $19.98 | 2023 | |
| Lilly USA, LLC | $19.48 | 2023 | Mounjaro |
| Dexcom, INC. | $15.70 | 2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.06 | 2024 | Jardiance, Tradjenta, Synjardy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.